These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

490 related articles for article (PubMed ID: 31871226)

  • 1. Immunity to Influenza Infection in Humans.
    Topham DJ; DeDiego ML; Nogales A; Sangster MY; Sant A
    Cold Spring Harb Perspect Med; 2021 Mar; 11(3):. PubMed ID: 31871226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cooperativity between CD8+ T cells, non-neutralizing antibodies, and alveolar macrophages is important for heterosubtypic influenza virus immunity.
    Laidlaw BJ; Decman V; Ali MA; Abt MC; Wolf AI; Monticelli LA; Mozdzanowska K; Angelosanto JM; Artis D; Erikson J; Wherry EJ
    PLoS Pathog; 2013 Mar; 9(3):e1003207. PubMed ID: 23516357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inactivated Influenza Vaccine That Provides Rapid, Innate-Immune-System-Mediated Protection and Subsequent Long-Term Adaptive Immunity.
    Chua BY; Wong CY; Mifsud EJ; Edenborough KM; Sekiya T; Tan AC; Mercuri F; Rockman S; Chen W; Turner SJ; Doherty PC; Kelso A; Brown LE; Jackson DC
    mBio; 2015 Oct; 6(6):e01024-15. PubMed ID: 26507227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The human antibody response to influenza A virus infection and vaccination.
    Krammer F
    Nat Rev Immunol; 2019 Jun; 19(6):383-397. PubMed ID: 30837674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment of memory CD8+ T cells with live attenuated influenza virus across different vaccination doses.
    Wang Z; Kedzierski L; Nuessing S; Chua BYL; Quiñones-Parra SM; Huber VC; Jackson DC; Thomas PG; Kedzierska K
    J Gen Virol; 2016 Dec; 97(12):3205-3214. PubMed ID: 27902386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal and integrative biomodeling of effector and memory immune compartments after inactivated influenza vaccination.
    Bonduelle O; Yahia N; Siberil S; Benhabiles N; Carrat F; Krivine A; Rozenberg F; Dimitrov J; Kaveri SV; Curjol A; Tindel M; Louet M; Desert F; Launay O; Loulergue P; Badre G; Katlama C; Bricaire F; Samri A; Rousset D; van der Werf S; Jauréguiberry S; Combadiere B
    J Immunol; 2013 Jul; 191(2):623-31. PubMed ID: 23776176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune responses to influenza virus infection.
    Kreijtz JH; Fouchier RA; Rimmelzwaan GF
    Virus Res; 2011 Dec; 162(1-2):19-30. PubMed ID: 21963677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human influenza viruses and CD8(+) T cell responses.
    Grant EJ; Quiñones-Parra SM; Clemens EB; Kedzierska K
    Curr Opin Virol; 2016 Feb; 16():132-142. PubMed ID: 26974887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-Protective Immune Responses Induced by Sequential Influenza Virus Infection and by Sequential Vaccination With Inactivated Influenza Vaccines.
    Dong W; Bhide Y; Sicca F; Meijerhof T; Guilfoyle K; Engelhardt OG; Boon L; de Haan CAM; Carnell G; Temperton N; de Vries-Idema J; Kelvin D; Huckriede A
    Front Immunol; 2018; 9():2312. PubMed ID: 30356772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Estimation of human and animal immunological memory by testing the trogocytosis of virus-specific T lymphocytes].
    Naĭkhin AN; Koren'kov DA; Chirkova TV; Petukhova GD; Donina SA; Rudenko LG
    Vopr Virusol; 2011; 56(5):15-21. PubMed ID: 22171472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. OVX836 Heptameric Nucleoprotein Vaccine Generates Lung Tissue-Resident Memory CD8+ T-Cells for Cross-Protection Against Influenza.
    Del Campo J; Bouley J; Chevandier M; Rousset C; Haller M; Indalecio A; Guyon-Gellin D; Le Vert A; Hill F; Djebali S; Leverrier Y; Marvel J; Combadière B; Nicolas F
    Front Immunol; 2021; 12():678483. PubMed ID: 34177921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meeting report and review: Immunological assays and correlates of protection for next-generation influenza vaccines.
    Krammer F; Weir JP; Engelhardt O; Katz JM; Cox RJ
    Influenza Other Respir Viruses; 2020 Mar; 14(2):237-243. PubMed ID: 31837101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chimeric hemagglutinin vaccine elicits broadly protective CD4 and CD8 T cell responses against multiple influenza strains and subtypes.
    Liao HY; Wang SC; Ko YA; Lin KI; Ma C; Cheng TR; Wong CH
    Proc Natl Acad Sci U S A; 2020 Jul; 117(30):17757-17763. PubMed ID: 32669430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparing for the Next Influenza Pandemic: The Development of a Universal Influenza Vaccine.
    Crank MC; Mascola JR; Graham BS
    J Infect Dis; 2019 Apr; 219(Suppl_1):S107-S109. PubMed ID: 30715413
    [No Abstract]   [Full Text] [Related]  

  • 15. Innate gene signature distinguishes humoral versus cytotoxic responses to influenza vaccination.
    Gonçalves E; Bonduelle O; Soria A; Loulergue P; Rousseau A; Cachanado M; Bonnabau H; Thiebaut R; Tchitchek N; Behillil S; van der Werf S; Vogt A; Simon T; Launay O; Combadière B
    J Clin Invest; 2019 May; 129(5):1960-1971. PubMed ID: 30843873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of neutralizing antibody and cell-mediated immune responses to pandemic H1N1 2009 influenza virus before and after H1N1 2009 influenza vaccination of elderly subjects and healthcare workers.
    Hsu JP; Phoon MC; Koh GC; Chen MI; Lee VJ; Wu Y; Xie ML; Cheong A; Leo YS; Chow VT
    Int J Infect Dis; 2012 Aug; 16(8):e621-7. PubMed ID: 22704721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of influenza virus infection by immunity to conserved viral features.
    Epstein SL
    Expert Rev Anti Infect Ther; 2003 Dec; 1(4):627-38. PubMed ID: 15482160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Quest for a Truly Universal Influenza Vaccine.
    Jang YH; Seong BL
    Front Cell Infect Microbiol; 2019; 9():344. PubMed ID: 31649895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-exposure treatment with whole inactivated H5N1 avian influenza virus protects against lethal homologous virus infection in mice.
    Hagan M; Ranadheera C; Audet J; Morin J; Leung A; Kobasa D
    Sci Rep; 2016 Jul; 6():29433. PubMed ID: 27405487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors affecting immune responses to the influenza vaccine.
    Castrucci MR
    Hum Vaccin Immunother; 2018 Mar; 14(3):637-646. PubMed ID: 28617077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.